Trials

Scope & Guideline

Exploring new frontiers in clinical research and methodology.

Introduction

Explore the comprehensive scope of Trials through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Trials in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationTRIALS / Trials
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Trials' is dedicated to the design, conduct, and analysis of clinical trials across a wide range of medical disciplines. It emphasizes the importance of methodological rigor and ethical considerations in clinical trial research, aiming to enhance the quality and transparency of clinical trials worldwide.
  1. Clinical Trial Design and Methodologies:
    The journal focuses on innovative designs and methodologies for clinical trials, including adaptive designs, Bayesian approaches, and stratified randomization, which aim to improve the efficiency and effectiveness of trials.
  2. Statistical Analysis and Reporting:
    A significant emphasis is placed on the statistical methods used in clinical trials, including estimands, time-to-event analyses, and handling of missing data, ensuring that results are robust and interpretable.
  3. Pragmatic and Real-World Trials:
    The journal covers pragmatic trials that reflect real-world clinical settings, aiming to produce findings that are applicable to everyday healthcare practice.
  4. Ethics and Regulatory Considerations:
    Ethical issues in clinical trials, such as informed consent, risk communication, and participant engagement, are central themes, as well as considerations related to regulatory compliance.
  5. Patient-Centered Approaches:
    The importance of incorporating patient perspectives and preferences in trial design and implementation is emphasized, advocating for more inclusive and representative research.
The journal 'Trials' has increasingly showcased themes that reflect current challenges and innovations in clinical research. These emerging scopes indicate a proactive approach to addressing contemporary issues in clinical trial design and implementation.
  1. Adaptive Trial Designs:
    There is a growing trend towards the use of adaptive trial designs, which allow for modifications based on interim data, enhancing flexibility and efficiency in clinical research.
  2. Integration of Real-World Evidence:
    Publications increasingly incorporate real-world evidence and observational data to complement findings from randomized trials, reflecting a broader understanding of how clinical interventions perform in everyday settings.
  3. Patient Engagement and Informed Consent:
    There is a significant rise in research focused on enhancing patient engagement in clinical trials, including innovative strategies for obtaining informed consent and improving participant retention.
  4. Use of Technology in Trials:
    Emerging themes highlight the use of digital tools and technologies, such as telehealth and electronic data capture, to facilitate trial processes and improve data quality.
  5. Focus on Health Equity and Diversity:
    Recent publications emphasize the importance of diversity in clinical trial populations and the need to address health disparities, reflecting a commitment to inclusive research practices.

Declining or Waning

As the field of clinical trials evolves, certain themes have shown a decline in prominence within the journal's recent publications. This may reflect shifts in research priorities or advancements in methodology that render previous approaches less relevant.
  1. Traditional Randomized Controlled Trials (RCTs) without Adaptive Features:
    There is a noticeable decrease in publications focusing purely on traditional RCTs, as more researchers are exploring adaptive designs that allow for modifications based on interim results.
  2. Single-Center Trials:
    Research focusing on single-center trials appears to be waning, likely due to a shift towards multi-center and collaborative trials that enhance generalizability and diversity of participants.
  3. Basic Statistical Methods:
    Papers that solely address basic statistical methods without integration into broader methodological frameworks are less common, as the field increasingly appreciates complex and advanced statistical approaches.

Similar Journals

Ethik in der Medizin

Navigating the Complexities of Medical Ethics
Publisher: SPRINGERISSN: 0935-7335Frequency: 4 issues/year

Ethik in der Medizin, published by Springer, is a distinguished journal focusing on the interdisciplinary aspects of ethics in medicine, healthcare policy, and philosophical inquiries related to these domains. With an ISSN of 0935-7335 and an E-ISSN of 1437-1618, this journal serves as a platform for innovative research and discussion from Germany and beyond. The journal boasts an impact in several prestigious categories including Q3 in Health Policy and Q2 in Philosophy as of 2023, reflecting its significant contribution to the discourse on ethical implications in health and medicine. Although not currently Open Access, Ethik in der Medizin provides valuable insights for researchers, professionals, and students interested in the complexities of health ethics and policies, positioning itself as an essential resource in academia. The journal is undergoing important developments, as it converges from 2001 with a publishing timeline extending to 2024, ensuring continued relevance in a rapidly evolving field.

Contemporary Clinical Trials Communications

Exploring the Frontiers of Pharmacology and Medicine
Publisher: ELSEVIER INCISSN: Frequency:

Contemporary Clinical Trials Communications, published by ELSEVIER INC, serves as a pivotal resource in the evolving fields of medicine and pharmacology, especially with its commitment to open access since 2015. With the E-ISSN 2451-8654, this journal is dedicated to disseminating high-quality research that examines contemporary clinical trial methodologies and their applications in improving healthcare outcomes. Situated in the United States, its impressive ranking, with a Q2 status in both Medicine (miscellaneous) and Pharmacology for 2023, highlights its significance and impact within the scientific community. Ranking #199 out of 636 in General Medicine and #217 out of 313 in Pharmacology on the Scopus scale, the journal aims to foster innovative discussions and developments among researchers, professionals, and students, making it an essential tool for those seeking to stay at the forefront of clinical research and trials.

Sociological Methodology

Advancing sociological inquiry through innovative methodologies.
Publisher: SAGE PUBLICATIONS INCISSN: 0081-1750Frequency: 1 issue/year

Sociological Methodology is a premier journal published by SAGE Publications Inc that serves as a vital platform for advancing the field of sociology through innovative methodological approaches. Since its inception, this esteemed journal has provided a rigorous forum for empirical and theoretical contributions in sociological research, making it an essential resource for both established scholars and emerging researchers. With an impressive Q1 ranking in both Social Sciences and Sociology and Political Science, as well as a notable position in the Scopus rankings, the journal ensures that published works meet the highest academic standards. Although it does not offer open access, its contributions have a significant impact on the field, and it enriches interdisciplinary dialogues through its diverse scope. The journal emphasizes the importance of methodological rigor and the application of cutting-edge techniques to address complex social issues, thereby shaping contemporary sociological discourse. Located in the United Kingdom, Sociological Methodology is dedicated to fostering scholarly communication and driving forward innovative research that challenges conventional paradigms.

Clinical Trials

Empowering healthcare through rigorous research.
Publisher: SAGE PUBLICATIONS LTDISSN: 1740-7745Frequency: 6 issues/year

Clinical Trials, published by SAGE Publications Ltd, is a prestigious journal that serves as a vital resource for researchers, professionals, and students in the fields of medicine and pharmacology. Operating since 2004 and converging through 2024, this journal boasts an impressive standing in the academic community, achieving a Q1 categorization in both Medicine (miscellaneous) and Pharmacology as of 2023. The journal's Scopus rankings reflect its influential contributions, with a rank of #128 out of 636 in General Medicine and a 79th percentile placement, alongside a rank of #172 out of 313 in Pharmacology, indicating its significant role in advancing clinical research. Based in the United Kingdom, Clinical Trials focuses on disseminating high-quality studies that enhance the understanding of clinical processes and therapeutic methodologies. Although it does not currently offer Open Access, the journal provides a platform for traditional publication, ensuring the dissemination of critical knowledge in the healthcare domain.

International Journal of Biostatistics

Advancing Global Health Through Statistical Insight.
Publisher: WALTER DE GRUYTER GMBHISSN: 2194-573XFrequency: 2 issues/year

The International Journal of Biostatistics, published by Walter de Gruyter GmbH, stands as a critical platform for advancements in the fields of biostatistics and applied statistics in medicine. With an ISSN of 2194-573X and an E-ISSN of 1557-4679, this journal has gained recognition for its rigorous peer-reviewed articles that bridge theoretical statistics and its practical applications in health sciences, maintaining a commendable Q2 quartile ranking in both Medicine and Statistics categories as of 2023. Hosted in Germany, the journal's pivotal role lies in disseminating innovative research findings that guide public health decisions and inform healthcare policy, thus appealing to a diverse readership including researchers, healthcare professionals, and students. Although the journal operates under a subscription model, it remains committed to providing valuable insights into the statistical methods that support evidence-based medicine and improve health outcomes globally. For those engaged in the evolving landscape of biostatistics, the International Journal of Biostatistics serves as an indispensable resource through its comprehensive coverage from 2005 to 2024.

ART JOURNAL

Exploring the Intersection of Visual and Performing Arts
Publisher: TAYLOR & FRANCIS INCISSN: 0004-3249Frequency: 4 issues/year

ART JOURNAL, published by Taylor & Francis Inc, is a distinguished journal in the field of Visual Arts and Performing Arts, boasting a commendable Q2 ranking in the latest 2023 category quartiles. With an ISSN of 0004-3249 and E-ISSN 2325-5307, this journal has been a vital platform for artistic discourse since its inception in 1960, detailing a rich lineage of research from 1960 to 1985 and from 1987 to the present. Acknowledged for its pedagogical value and scholarly contributions, the ART JOURNAL ranks #220 out of 667 in the Scopus database, placing it in the 67th percentile among its peers. Despite not currently providing open access options, the journal remains an invaluable resource for researchers, professionals, and students in the arts, fostering an environment for innovative thought and stimulating scholarly exchange.

Journal of EMDR Practice and Research

Pioneering Healing: The Journal for EMDR Practitioners
Publisher: SPRINGER PUBLISHING COISSN: 1933-3196Frequency: 4 issues/year

Journal of EMDR Practice and Research, published by Springer Publishing Co, is an essential resource for professionals in the field of psychology and mental health, focusing specifically on Eye Movement Desensitization and Reprocessing (EMDR) therapy. Established in 2010, the journal spans a significant academic horizon, aiming to disseminate high-quality research and practical applications of EMDR in clinical settings. With an increasing scope that intersects with Biological Psychiatry, Cognitive Neuroscience, and Neuropsychology, the journal occupies an important niche evidenced by its latest Scopus rankings, including a Q3 classification in Experimental and Cognitive Psychology. Researchers and clinicians benefit from access to emerging findings that can inform their practices, ultimately improving the treatment outcomes for individuals facing trauma and related disorders. Although specific open access options may not be available, the journal remains committed to upholding high standards of scholarly contribution in the realm of mental health.

Therapeutic Innovation & Regulatory Science

Exploring Innovations at the Intersection of Health and Compliance
Publisher: SPRINGER HEIDELBERGISSN: 2168-4790Frequency: 6 issues/year

Therapeutic Innovation & Regulatory Science, published by Springer Heidelberg, is an esteemed journal that focuses on the intersection of therapeutic innovations and the regulatory frameworks that govern them. Established in 1970 and continuing its legacy of excellence through converged years, this journal plays a crucial role in supplying cutting-edge research, reviews, and discussions that advance understanding in the fields of pharmacology and healthcare regulation. With an impact factor reflective of its rigorous peer-review standards, this journal holds a prestigious Q1 ranking in Pharmacology, Toxicology, and Pharmaceutics (Miscellaneous) for 2023, reflecting its influence and the high quality of its published material. The journal's wide scope also embraces public health and environmental studies, making it an essential resource for researchers and professionals navigating these critical areas. Open access options enhance its visibility and accessibility, ensuring that the latest discoveries and regulatory insights are readily available to a global audience. For those at the forefront of medicinal science and regulatory affairs, Therapeutic Innovation & Regulatory Science is your avenue to understanding pivotal innovations that shape contemporary therapeutic practices.

Field Methods

Bridging Theory and Practice in Contemporary Anthropology.
Publisher: SAGE PUBLICATIONS INCISSN: 1525-822XFrequency: 4 issues/year

Field Methods, an esteemed journal published by SAGE Publications Inc, specializes in the realm of Anthropology, presenting innovative research methodologies that shape contemporary anthropological inquiry. With an impressive impact factor reflected in its 2023 Scopus ranking as #81 out of 502 in the field of Social Sciences, this Q1 journal serves as a critical platform for academics, professionals, and students committed to advancing ethnographic research and methodological discourse. The journal, established in 1989, has embraced an interdisciplinary approach, encouraging submissions that explore both qualitative and quantitative methods across diverse contexts. While access options are not open access, subscribers benefit from comprehensive insights into the methodologies that underpin anthropological studies. As Field Methods approaches its converged years until 2024, it continues to play a pivotal role in informing and inspiring the next generation of scholars and practitioners aiming to enrich our understanding of cultures and communities worldwide.

Contemporary Clinical Trials

Transforming Ideas into Impactful Studies
Publisher: ELSEVIER SCIENCE INCISSN: 1551-7144Frequency: 6 issues/year

Contemporary Clinical Trials, published by Elsevier Science Inc, stands at the forefront of clinical research, providing a dedicated platform for the dissemination of innovative studies and methodologies in medicine and pharmacology. With an impressive impact factor reflecting its consistent contributions to the field, this journal is categorized in the Q1 quartile for both Medicine (miscellaneous) and Pharmacology (medical) as of 2023. The journal's scope encompasses a broad range of topics pertinent to clinical trial design, execution, and analysis, aiming to enhance the effectiveness and safety of therapeutic interventions. Operating under an Open Access model, it ensures that the latest research is accessible to a global audience, fostering collaboration and discussion among researchers, professionals, and students alike. In publishing high-quality articles since its inception in 2005, Contemporary Clinical Trials continues to shape the future of clinical research with its commitment to excellence and innovation.